TC BioPharm (Holdings) Bolsa (NASDAQ: TCBP)

Últimas noticias sobre TC BioPharm (Holdings) (NASDAQ:TCBP) Bolsa

TC BioPharm (Holdings)

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings) PLC

WIIM

SNES

SenesTech shares are trading lower after the company announced the exercise of warrants and will issue 1.498,872 shares of common stock.

Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) reported quarterly earnings of $0.14 per share. This is a 16.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported $11.54 million in sales this quarter. This is a 22.18 percent increase over sales of $9.45 million the same period last year.

Earnings

News

DXST

Decent Holding FY EPS $0.14 Up From $0.12 YoY, Sales $11.54M Up From $9.45M YoY

Management

FLUX

Flux Power Appoints Krishna Vanka As Chief Executive Officer, Effective March 10, 2025

Biotech

Earnings Misses

General

INZY

Inozyme Pharma FY 2024 GAAP EPS $(1.62) Misses $(1.60) Estimate; Co. Prioritizes Activities To Support Planned Biologics License Application Filing For INZ-701 In ENPP1 Deficiency, Announces 25% Workforce Reduction

Baird analyst Andrew Wittmann maintains WillScot Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) with a Neutral and lowers the price target from $38 to $32.

Price Target

Analyst Ratings

Baird Maintains Neutral on WillScot Holdings, Lowers Price Target to $32

SYNX

Silynxcom Has Received Two New Purchase Orders From An Elite Special Forces Unit Of The Israel Defense Forces For Advanced Tactical Communication Systems

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Compass Point analyst Floris Van Dijkum downgraded the rating for Pebblebrook Hotel Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) from Buy to Neutral. Pebblebrook Hotel shares closed at $12.11 on Friday. <a href="https://www.benzinga.com/quote/PEB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point analyst Floris Van Dijkum downgraded Host Hotels &amp; Resorts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) from Buy to Neutral and lowered the price target from $20 to $18. Host Hotels shares closed at $16.33 on Friday. <a href="https://www.benzinga.com/quote/HST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Laurence Alexander downgraded The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Buy to Hold and lowered the price target from $423 to $380. Sherwin-Williams shares closed at $363.62 on Friday. <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Julian Mitchell downgraded Emerson Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from Equal-Weight to Underweight and cut the price target from $135 to $110. Emerson Electric shares closed at $118.61 on Friday. <a href="https://www.benzinga.com/quote/EMR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Blaine Heck downgraded the rating for Kilroy Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) from Overweight to Equal-Weight and lowered the price target from $43 to $35. Kilroy Realty shares closed at $33.32 on Friday. <a href="https://www.benzinga.com/quote/KRC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SHW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-1024x577.png" alt="" class="wp-image-816551" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

Downgrades

Pre-Market Outlook

Markets

Trading Ideas

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) ("SEALSQ" or "Company"), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced the signing of new distribution and sales agreements, significantly expanding the company's global footprint across Europe, Asia, and the Middle East. These agreements will enhance SEALSQ's ability to deliver its secure microcontrollers, post-quantum-ready solutions, and secure hardware platforms to a broader range of customers and industries worldwide.
New Distribution &amp; Sales Partnerships
<ul>
<li>Ozdisan – <a href="https://www.ozdisan.com/">https://www.ozdisan.com</a> &nbsp;</li>
</ul>
Covering Turkey, Egypt, and Greece, Ozdisan is one of the largest electronic component distributors in the region, with a strong focus on industrial applications, automotive electronics, and IoT solutions. Their deep market knowledge and extensive logistics capabilities position them as a key partner to accelerate SEALSQ's presence in these strategically important markets.
<ul>
<li>DTDS Technology – <a href="https://www.dtdsgroup.com/">https://www.dtdsgroup.com</a> &nbsp;</li>
</ul>
Operating across India, Singapore, Philippines, Thailand, Malaysia, Indonesia, and Vietnam, DTDS is a well-established distributor specializing in embedded systems, IoT components, and advanced semiconductor solutions. With their technical expertise and strong customer network, DTDS will help SEALSQ effectively support regional demand for secure hardware and post-quantum technologies.
<ul>
<li>Steliau Technology – <a href="https://www.steliau-technology.com/">https://www.steliau-technology.com</a> &nbsp;</li>
</ul>
Serving France, Spain, and Italy, Steliau is recognized for its engineering-driven approach, offering customized solutions and design support for industrial, consumer, and automotive electronics sectors. Their ability to provide value-added services will help SEALSQ deliver tailored security solutions that meet the evolving requirements of European manufacturers.
<ul>
<li>Nexus-GT – <a href="https://www.nexus-gt.com/">https://www.nexus-gt.com</a> &nbsp;</li>
</ul>
Based in Israel, Nexus-GT brings extensive experience as a manufacturer's representative, specializing in high-tech and semiconductor solutions. Their strong relationships with leading Israeli technology companies and deep understanding of the local innovation ecosystem will be instrumental in expanding SEALSQ's market presence in Israel's highly competitive technology landscape.

Global

LAES

SEALSQ Expands Global Reach With New Distribution And Sales Agreements Across Europe, Asia, And The Middle East, Enhancing Ability To Deliver Its Secure Microcontrollers, Post-Quantum-Ready Solutions, And Secure Hardware Platforms To A Broader Range Of Customers And Industries Worldwide

BLBX

Blackboxstocks shares are trading higher after the company signed a definitive merger agreement to acquire rare earth producer REalloys.

Buybacks

DAVE

Dave Authorizes $50M Share Buyback

<ul>
<li>Upon closing of the Merger, it is anticipated Blackbox's and REalloys' stockholders will own approximately 7.3% and 92.7%, respectively, of the combined company's shares of common stock expected to be outstanding upon closing of the Merger, based on REalloys' initial valuation of $400 million.</li>
<li>Blackbox's stockholders of record prior to closing will receive Contingent Value Rights (CVRs) entitling them to certain net proceeds from the potential sale of Blackbox's current fintech operations within 24 months post-Merger.</li>
<li>Post-closing, David Argyle is expected to assume the role of Chief Executive Officer of the combined company, while Gust Kepler will continue as Chief Executive Officer of Blackbox.io, Inc., a subsidiary formed to continue the Company's historic fintech operations. REalloys will appoint five members and current management of Blackbox will appoint one member to the board of directors of the post-Merger combined company.</li>
<li>Blackbox and REalloys plan to work together to file a Registration Statement and Proxy Statement on Form S-4 to obtain approval of the Merger (the "Merger Registration Statement"). The Merger is expected to close in the second quarter of 2025 and is subject to customary closing conditions including but not limited to regulatory, lender and stockholder approval</li>
</ul>

Blackboxstocks Enteres Into A Definitive Merger Agreement to Acquire REalloys. Upon Closing Its Anticipated Blackbox's And REalloys' Stockholders Will Own ~ 7.3% and ~92.7%, respectively

Amentum Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>) ("Amentum") announced today the launch of a secondary underwritten public offering (the "Offering") of 19,464,174 shares of its common stock (the "Shares"). Amentum is not selling any shares of common stock and will not receive any proceeds from the sale of the Shares in the Offering or from the debt-for-equity exchange (as described below).
In connection with the Offering, a subsidiary of Jacobs Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) ("Jacobs") is expected to exchange 19,464,174 shares of Amentum's common stock for indebtedness of such subsidiary held by an affiliate of BofA Securities, Inc. (the "Selling Shareholder"). Following the debt-for-equity exchange, if consummated, the Selling Shareholder intends to sell the Shares to the underwriters in the Offering. After the completion of the proposed Offering, Jacobs will no longer own any shares of Amentum's common stock, other than shares Jacobs may receive upon release of 9,732,087 shares of Amentum common stock that remain in escrow, subject to final determination of certain performance milestones in connection with post-closing adjustments to the merger consideration relating to the combination of Jacobs' Critical Mission Solutions and Cyber &amp; Intelligence businesses with Amentum Parent Holdings LLC.
BofA Securities, J.P. Morgan, Morgan Stanley, BNP Paribas and TD Cowen are acting as joint book-running managers for the Offering.

Offerings

AMTM

Amentum Announces The Launch Of A Secondary Underwritten Public Offering Of 19,464,174 Shares Of Its Common Stock; In Connection With The Offering, A Subsidiary Of Jacobs Solutions Is Expected To Exchange 19,464,174 Shares Of Amentum's Common Stock

CTCX

Longevity Health Holdings, Inc. - Common Stock

XAGE

Carmell Rebrands As Longevity Health Holdings: To Trade Under "XAGE"

RSLS

ReShape Lifesciences Receives Notice Of Allowance For US Patent Related To Its Diabetes Neuromodulation Technology

OKYO

OKYO Pharma Files For Fast Track Designation With FDA For Urcosimod To Treat Neuropathic Corneal Pain

BTDR

Bitdeer Technologies Group shares are trading lower after the company completed its latest SEAL03 Bitcoin mining chip testing.

Baird analyst Peter Arment initiates coverage on Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) with a Outperform rating and announces Price Target of $40.

Initiation

KRMN

Baird Initiates Coverage On Karman Holdings with Outperform Rating, Announces Price Target of $40

Danaher 's Beckman Coulter Announces FDA Clearance Of Its DxC 500i Clinical Analyzer

Rand Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>) reported quarterly earnings of $0.45 per share. This is a 12.5 percent increase over earnings of $0.40 per share from the same period last year. The company reported $2.14 million in sales this quarter. This is a 10.73 percent increase over sales of $1.93 million the same period last year.

RAND

Rand Capital Q4 Adj $0.45 Up From $0.40 YoY, Sales $2.14M Up From $1.93M YoY

CKPT

Checkpoint Therapeutics shares are trading higher after Sun Pharma announced it will acquire the company in a $365 million deal.

Press Releases

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

Dividends

/C O R R E C T I O N -- TC BioPharm/

TCBP to Present at Sequire Investor Summit 2025

TCBP Announces H5N1 Proof of Concept Studies Intention

TCBP to Implement ADS Ratio Change

TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

Small Cap

TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

Comments

TC BioPharm (Holdings)

Noticias

Últimas noticias sobre TC BioPharm (Holdings) (NASDAQ:TCBP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL